Alto Neuroscience, INC. (ANRO) SEC Filings — 2025

Filings

• Alto Narrows Quarterly Loss, Boosts Capital with $49.9M Private Placement — 10-Q · Nov 12, 2025
• Alto Neuroscience 8-K: Agreements, Sales, and Other Events — 8-K · Oct 20, 2025
• Alto Neuroscience Losses Widen Amid Stable R&D Spend — 10-Q · Aug 13, 2025
• Alto Neuroscience Announces Director Changes — 8-K · Jul 8, 2025
• Alto Neuroscience Files 8-K Report — 8-K · Jun 26, 2025
• Alto Neuroscience Files 8-K — 8-K · Jun 3, 2025
• Alto Neuroscience Files Q1 2025 10-Q — 10-Q · May 14, 2025
• Alto Neuroscience Files 2025 Proxy Statement — DEF 14A · Apr 1, 2025
• Alto Neuroscience, INC. 10-K Filing — 10-K · Mar 20, 2025
• Alto Neuroscience Files 8-K — 8-K · Feb 12, 2025
• Alto Neuroscience Files 8-K with Definitive Agreement Update — 8-K · Feb 3, 2025
• Alto Neuroscience Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 16, 2025